Sumitomo Pharma Co., Ltd. (4506.T) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Nikkei 225

Sumitomo Pharma Co., Ltd. (4506.T) closed at JPY 1,842.00 on 2026-10-15, a change of +11.4 % over the past year, with a market capitalization of JPY 825.64B.

Sumitomo Pharma Co., Ltd. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Sumitomo Pharma Co., Ltd. key figures

Previous close

JPY 1,842.00 (2026-10-15)

1-year change

+11.4 %

Market cap

JPY 825.64B

Enterprise value

JPY 909.65B

P/E ratio (trailing)

7.53

P/E ratio (forward)

107.44

EPS (trailing)

244.57

EPS (forward)

17.13

PEG ratio

1.93

Price to book

2.02

Revenue growth

19.9 %

Earnings growth

38.3 %

Dividend per share (trailing)

0.00

Short ratio

n/a

Employees

n/a

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Sumitomo Pharma Co., Ltd. and compare it with other stocks.